TrialJournal of internal medicine2019

Urinary excretion of homocysteine thiolactone and the risk of acute myocardial infarction in coronary artery disease patients: the WENBIT trial.

K Borowczyk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.